Respiratory failure & ventilation

Exploring the therapeutic role of early heparin administration in acute respiratory distress syndrome (ARDS) management: a MIMIC-IV database analysis

J Intensive CarePublished Retrospective cohort study

Authors' conclusion

This research highlights that early prophylactic administration of heparin may substantially lower mortality in ARDS patients.

Study context

Population
ARDS patients in the MIMIC-IV database
Exposure
Heparin vs No heparin
Outcome
In-hospital mortality
Methodological detailspropensity score matching, inverse probability weighting
  • Propensity score matching
  • Inverse probability weighting

Main finding

As reported in the abstract

Heparin vs No heparinHazard ratio (95% CI)P value
Unmatched
0.71(0.54–0.93)
P = 0.012
After propensity score matching (12.75% vs 17.93%)
0.65(0.47–0.90)
P = 0.010

Observational data: associations, not effects.

Secondary outcomes

OutcomeHR (95% CI)P value
In-hospital mortality, alternative statistical models (sensitivity analysis)Heparin vs No heparin · doubly robust model without balanced covariates0.669 (0.487–0.919)P = 0.013
In-hospital mortality, alternative statistical models (sensitivity analysis)Heparin vs No heparin · doubly robust model with all covariates0.705 (0.515–0.965)P = 0.029
In-hospital mortality, alternative statistical models (sensitivity analysis)Heparin vs No heparin · propensity score (IPW) model0.660 (0.491–0.888)P = 0.006
In-hospital mortality, alternative statistical models (sensitivity analysis)Heparin vs No heparin · propensity score matching model0.650 (0.470–0.900)P = 0.010
In-hospital mortality, alternative statistical models (sensitivity analysis)Heparin vs No heparin · multivariate Cox regression model0.706 (0.536–0.930)P = 0.013

Mortality at 60 and 90 days

Heparin use associated with reduced mortality at 60 and 90 days

Original publication

Exploring the therapeutic role of early heparin administration in ARDS management: a MIMIC-IV database analysis. J Intensive Care. Published 26 February 2024. doi:10.1186/s40560-024-00723-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.